Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 342 articles:
HTML format



Single Articles


    July 2021
  1. WANG SX, Marshall MB
    Commentary: A new hope: Do ADAURA trial results change the paradigm for treatment of resectable lung adenocarcinoma?
    J Thorac Cardiovasc Surg. 2021;162:293-294.
    PubMed    


  2. ANTONOFF MB, Morris VK
    Reply from author: Biology is king, but metastasectomy still has a role for properly selected patients.
    J Thorac Cardiovasc Surg. 2021;162:e136-e138.
    PubMed    


  3. CAMERON RB
    Reply: Discussions regarding pulmonary metastasectomy are similar to American politics: Both are extremely polarizing, unsatisfying, inconclusive, and undertaken at your own peril.
    J Thorac Cardiovasc Surg. 2021;162:e135-e136.
    PubMed    


  4. HIRPARA DH, Kidane B
    Commentary: VATS, RATS, stats, and some caveats.
    J Thorac Cardiovasc Surg. 2021;162:269-270.
    PubMed    


  5. SIHAG S
    Commentary: Sarcomas and sarcomatoid tumors of the lung...not your average lung cancers.
    J Thorac Cardiovasc Surg. 2021;162:285-286.
    PubMed    


  6. JONES DR, Wu YL, Tsuboi M, Herbst RS, et al
    Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons.
    J Thorac Cardiovasc Surg. 2021;162:288-292.
    PubMed    


  7. CORSINI EM, Mitchell KG, Correa A, Morris VK, et al
    Effect of primary colorectal cancer tumor location on survival after pulmonary metastasectomy.
    J Thorac Cardiovasc Surg. 2021;162:296-305.
    PubMed     Abstract available


  8. ROBINSON LA, Babacan NA, Tanvetyanon T, Henderson-Jackson E, et al
    Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas.
    J Thorac Cardiovasc Surg. 2021;162:274-284.
    PubMed     Abstract available


  9. KAMEL MK, Lee B, Harrison SW, Port JL, et al
    Sublobar resection is comparable to lobectomy for screen-detected lung cancer.
    J Thorac Cardiovasc Surg. 2021 Jul 1. pii: S0022-5223(21)01011.
    PubMed     Abstract available


    May 2021
  10. ISBELL JM, Li BT, Gomez DR
    The emerging role of local therapy in oligometastatic non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021 May 29. pii: S0022-5223(21)00875.
    PubMed    


  11. DONINGTON JS
    Commentary: Why do we operate in metastatic lung cancer?
    J Thorac Cardiovasc Surg. 2021 May 8. pii: S0022-5223(21)00771.
    PubMed    


  12. WIGHTMAN SC, Kim AW
    Commentary: When less is more for lung cancers.
    J Thorac Cardiovasc Surg. 2021;161:1650-1651.
    PubMed    


  13. CERFOLIO RJ
    Commentary: Let us raise the bar higher for better patient outcomes.
    J Thorac Cardiovasc Surg. 2021;161:1649-1650.
    PubMed    


  14. WEKSLER B, Sullivan JL, Schumacher LY
    Randomized trial of bupivacaine with epinephrine versus bupivacaine liposome suspension in patients undergoing minimally invasive lung resection.
    J Thorac Cardiovasc Surg. 2021;161:1652-1661.
    PubMed     Abstract available


    April 2021
  15. FERNANDEZ R, Ahmad U
    Commentary: A new hope-neoadjuvant immunotherapy for resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021 Apr 27. pii: S0022-5223(21)00740.
    PubMed    


  16. BONNER SN, Wakeam E
    The volume-outcome relationship in lung cancer surgery: The impact of the social determinants of health care delivery.
    J Thorac Cardiovasc Surg. 2021 Apr 20. pii: S0022-5223(21)00593.
    PubMed    


  17. TONG BC, Gu L, Wang X, Wigle DA, et al
    Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021 Apr 9. pii: S0022-5223(21)00583.
    PubMed     Abstract available


  18. GROTH SS, Ripley RT
    Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1519-1520.
    PubMed    


  19. EBRIGHT MI
    Commentary: Acute kidney injury after intrapleural cisplatin: Minimizing collateral damage.
    J Thorac Cardiovasc Surg. 2021;161:1522-1523.
    PubMed    


  20. BRIBRIESCO A
    Commentary: Winning the battle for local control without losing war for survival against malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1520-1522.
    PubMed    


  21. VARELA G
    Commentary: Extended disease, but still not the end for patients.
    J Thorac Cardiovasc Surg. 2021;161:1507-1508.
    PubMed    


  22. STILES BM
    Commentary: Think systemically, act locally.
    J Thorac Cardiovasc Surg. 2021;161:1505-1506.
    PubMed    


  23. VEERAMACHANENI NK
    Commentary: Ground-glass opacity-an unexpected silver lining.
    J Thorac Cardiovasc Surg. 2021;161:1481-1482.
    PubMed    


  24. YENDAMURI S
    Commentary: A picture really is worth a thousand words.
    J Thorac Cardiovasc Surg. 2021;161:1482-1483.
    PubMed    


  25. HOD T, Freedberg KJ, Motwani SS, Chen M, et al
    Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1510-1518.
    PubMed     Abstract available


    March 2021
  26. ELY S, Jiang SF, Dominguez DA, Patel AR, et al
    Effect of thoracic surgery regionalization on long-term survival after lung cancer resection.
    J Thorac Cardiovasc Surg. 2021 Mar 20. pii: S0022-5223(21)00530.
    PubMed     Abstract available


  27. ANTONOFF MB, Sofocleous CT, Callstrom MR, Nguyen QN, et al
    The roles of surgery, stereotactic radiation, and ablation for treatment of pulmonary metastases.
    J Thorac Cardiovasc Surg. 2021 Mar 6. pii: S0022-5223(21)00423.
    PubMed    


  28. TONG BC
    Commentary: Safety first!
    J Thorac Cardiovasc Surg. 2021;161:803-804.
    PubMed    


  29. RAYMOND DP
    Commentary: We need more surgeons!
    J Thorac Cardiovasc Surg. 2021;161:804-805.
    PubMed    


  30. IMAI T, Weksler B
    Commentary: Eurolung score as a predictor of long-term survival: It is not all about the tumor.
    J Thorac Cardiovasc Surg. 2021;161:788-789.
    PubMed    


  31. DONAHOE LL, Nason GJ, Bedard PL, Hansen AR, et al
    Pathologic concordance of resected metastatic nonseminomatous germ cell tumors in the chest.
    J Thorac Cardiovasc Surg. 2021;161:856-868.
    PubMed     Abstract available


  32. SHEMANSKI KA, Farias A, Lieu D, Kim AW, et al
    Understanding thoracic surgeons' perceptions of administrative database analyses and guidelines in clinical decision-making.
    J Thorac Cardiovasc Surg. 2021;161:807-816.
    PubMed     Abstract available


    February 2021
  33. IMAI T, Weksler B
    Commentary: Open or VATS? Roll up your sleeve.
    J Thorac Cardiovasc Surg. 2021;161:414-415.
    PubMed    


  34. CHUDGAR NP, Bott MJ
    Commentary: Minimally invasive sleeve lobectomy: Time to roll up our "sleeves" and learn something new?
    J Thorac Cardiovasc Surg. 2021;161:415-416.
    PubMed    


  35. RIPLEY RT
    Commentary: Drawing the target after shooting the arrow: The importance of trial design.
    J Thorac Cardiovasc Surg. 2021;161:443-444.
    PubMed    


  36. GERACI TC, Ng T
    Commentary: Overreliance of propensity-score matched studies in thoracic surgery.
    J Thorac Cardiovasc Surg. 2021;161:417-418.
    PubMed    


    January 2021
  37. VEERAMACHANENI NK
    Commentary: Computed tomography screening for lung cancer at large in China: Early cure or definitive overtreatment?
    J Thorac Cardiovasc Surg. 2021 Jan 13. pii: S0022-5223(21)00047.
    PubMed    


  38. YE T, Chen H
    Commentary: The ground-glass opacity: "The savior" for lung cancer?
    J Thorac Cardiovasc Surg. 2021 Jan 8. pii: S0022-5223(21)00014.
    PubMed    


    December 2020
  39. WATANABE Y, Hattori A, Nojiri S, Matsunaga T, et al
    Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Dec 29. pii: S0022-5223(20)33443.
    PubMed     Abstract available


  40. VAN RAEMDONCK D, Decaluwe H, De Leyn P, Nackaerts K, et al
    Commentary: Do we need to search for a patient's cigarettes or just count his or her wrinkles when counseling for lung cancer resection?
    J Thorac Cardiovasc Surg. 2020 Dec 25. pii: S0022-5223(20)33404.
    PubMed    


  41. HEIDEN BT, Subramanian MP, Puri V, Kozower BD, et al
    Striking a balance: Surveillance of non-small cell lung cancer after resection.
    J Thorac Cardiovasc Surg. 2020 Dec 10. pii: S0022-5223(20)33342.
    PubMed    


  42. AL NATOUR RH, He C, Clark MJ, Welsh R, et al
    The influence of tobacco load versus smoking status on outcomes following lobectomy for lung cancer in a statewide quality collaborative.
    J Thorac Cardiovasc Surg. 2020 Dec 10. pii: S0022-5223(20)33305.
    PubMed     Abstract available


  43. ABBAS AE
    Commentary: The value of close surveillance after lung cancer surgery: How absence of evidence is not evidence of absence.
    J Thorac Cardiovasc Surg. 2020 Dec 3. pii: S0022-5223(20)33213.
    PubMed    


  44. HENNON M, Groman A, Kumar A, Castaldo L, et al
    Correlation between perioperative outcomes and long-term survival for non-small lung cancer treated at major centers.
    J Thorac Cardiovasc Surg. 2020 Dec 3. pii: S0022-5223(20)33194.
    PubMed     Abstract available


  45. LIU C, Liao H, Guo C, Pu Q, et al
    Single-direction thoracoscopic basal segmentectomy.
    J Thorac Cardiovasc Surg. 2020;160:1586-1594.
    PubMed     Abstract available


    November 2020
  46. D'AMICO TA
    Commentary: Surgery for small cell lung cancer: This is the way.
    J Thorac Cardiovasc Surg. 2020 Nov 28. pii: S0022-5223(20)33173.
    PubMed    


  47. ZHOU N, Bott M, Park BJ, Vallieres E, et al
    Predictors of survival following surgical resection of limited-stage small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 27. pii: S0022-5223(20)33137.
    PubMed     Abstract available


  48. ONAITIS M
    Commentary: Survival after small cell lung cancer resection: Small opportunity?
    J Thorac Cardiovasc Surg. 2020 Nov 24. pii: S0022-5223(20)33131.
    PubMed    


  49. SWANSON SJ
    Commentary: Find, resect, and treat: The evolving early-stage small cell lung cancer story.
    J Thorac Cardiovasc Surg. 2020 Nov 21. pii: S0022-5223(20)33080.
    PubMed    


  50. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    Respiratory strength and pectoralis muscle mass as measures of sarcopenia: Relation to outcomes in resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 19. pii: S0022-5223(20)33059.
    PubMed     Abstract available


  51. SUZUKI K, Watanabe SI, Wakabayashi M, Saji H, et al
    A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 12. pii: S0022-5223(20)33043.
    PubMed     Abstract available


  52. SESTI J, Paul S
    Commentary: Burn, baby, burn.
    J Thorac Cardiovasc Surg. 2020;160:1348-1349.
    PubMed    


  53. KIM SS, Bharat A
    Commentary: Video-assisted thoracoscopic surgery versus robotic assisted surgery: Are we asking the right question?
    J Thorac Cardiovasc Surg. 2020;160:1374-1375.
    PubMed    


  54. LIN J
    Commentary: The wizard of OS: Is overall survival better after sublobar resection versus stereotactic radiation or ablation?
    J Thorac Cardiovasc Surg. 2020;160:1358-1359.
    PubMed    


  55. LANUTI M
    Commentary: Can big data effectively answer important clinical questions?
    J Thorac Cardiovasc Surg. 2020;160:1361-1362.
    PubMed    


  56. SONG KJ, Flores RM
    Commentary: Robot-assisted segmentectomy is safe and expensive-What is the debate?
    J Thorac Cardiovasc Surg. 2020;160:1373-1374.
    PubMed    


  57. DENLINGER CE
    Commentary: To wedge or not to wedge.
    J Thorac Cardiovasc Surg. 2020;160:1359-1360.
    PubMed    


    October 2020
  58. TSUTANI Y, Handa Y, Shimada Y, Ito H, et al
    Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 22. pii: S0022-5223(20)32833.
    PubMed     Abstract available


  59. BEAMER S, D'Cunha J
    Commentary: Using the entire toolbox for improved survival in anaplastic lymphoma kinase-positive non-small cell lung cancer: The next normal?
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32858.
    PubMed    


  60. MUENYI C, Ng T
    Commentary: Sublobar resection, closing in as the standard in surgical management for a subgroup of patients with lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32848.
    PubMed    


  61. MUNIAPPAN A
    Commentary: One size does not fit ALK-Targeted therapy, local ablation of recurrence, and improved outcomes after resection of ALK-positive lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32856.
    PubMed    


  62. LANUTI M
    Commentary: Comparing sleeve lobectomy with pneumonectomy for central lung cancer: A randomized study will never be conducted.
    J Thorac Cardiovasc Surg. 2020 Oct 13. pii: S0022-5223(20)32818.
    PubMed    


  63. SCARCI M, Raveglia F
    Commentary: Ground-glass opacity-dominant lung cancer. Is every R0 wedge resection always a good wedge resection?
    J Thorac Cardiovasc Surg. 2020 Oct 13. pii: S0022-5223(20)32830.
    PubMed    


  64. PASS HI
    Commentary: Tasting individual ingredients of meso soup: Can 'omics bring out the flavor?
    J Thorac Cardiovasc Surg. 2020;160:1084-1085.
    PubMed    


  65. SEVERSON DT, De Rienzo A, Bueno R
    Mesothelioma in the age of "Omics": Before and after The Cancer Genome Atlas.
    J Thorac Cardiovasc Surg. 2020;160:1078-1083.
    PubMed    


  66. RIPLEY RT
    Commentary: Filling up my truck from an oil tanker: Can big 'omic' data influence our clinical decisions?
    J Thorac Cardiovasc Surg. 2020;160:1086-1087.
    PubMed    


  67. DAVID EA, Atay SM
    Commentary: To scan or not to scan: No longer the question for mesothelioma patients after pleurectomy.
    J Thorac Cardiovasc Surg. 2020;160:1076-1077.
    PubMed    


  68. CAMERON RB
    Commentary: Mesothelioma: The Guinness world record holder in thromboembolism.
    J Thorac Cardiovasc Surg. 2020;160:1074-1075.
    PubMed    


  69. DEMMY TL
    Commentary: Positive pressure toward a negative trial?
    J Thorac Cardiovasc Surg. 2020;160:1062-1063.
    PubMed    


  70. CORSINI EM, Antonoff MB
    Commentary: Work in progress-Defining optimal surgical prehabilitation before lung resection.
    J Thorac Cardiovasc Surg. 2020;160:1060-1061.
    PubMed    


  71. DE LEON LE, Bravo-Iniguez CE, Fox S, Tarascio J, et al
    Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;160:1064-1073.
    PubMed     Abstract available


    September 2020
  72. HO H, Williamson C, Regis SM, Stock CT, et al
    Surgery and invasive diagnostic procedures for benign disease are rare in a large low-dose computed tomography lung cancer screening program.
    J Thorac Cardiovasc Surg. 2020 Sep 8. pii: S0022-5223(20)32573.
    PubMed     Abstract available


  73. RAKOVICH G, Bujold A
    The "multispecialty clinic": Toward a new paradigm in thoracic oncology?
    J Thorac Cardiovasc Surg. 2020;160:e176-e177.
    PubMed    


  74. MORI M, Geirsson A
    Reply from authors: Identifying lessons that could be generalized across different disease burdens.
    J Thorac Cardiovasc Surg. 2020;160:e133-e134.
    PubMed    


  75. SONG KJ, Flores RM
    REPLY: ROBOTIC-ASSISTED SEGMENTECTOMY: DOING IT SIMPLY BECAUSE WE CAN?
    J Thorac Cardiovasc Surg. 2020;160:e176.
    PubMed    


  76. MADARIAGA ML, Gaissert HA
    Reply from authors: The many benefits of a multidisciplinary evaluation of lung nodules.
    J Thorac Cardiovasc Surg. 2020;160:e177-e178.
    PubMed    


  77. ZHANG Y, Chen X, Li H
    Robotic or thoracoscopic segmentectomy: Each complements the other.
    J Thorac Cardiovasc Surg. 2020;160:e175.
    PubMed    


  78. VEERAMACHANENI NK
    Commentary: Minimally invasive sleeve lobectomy-from case report curiosity to standard of care?
    J Thorac Cardiovasc Surg. 2020;160:852-853.
    PubMed    


  79. CERFOLIO RJ
    Commentary: Why so many sleeve resections and pneumonectomies and why the nonabsorbable suture?
    J Thorac Cardiovasc Surg. 2020;160:847-848.
    PubMed    


  80. LAZZARO R, Patton B
    Commentary: Maximum surgery through minimal incisions.
    J Thorac Cardiovasc Surg. 2020;160:849-850.
    PubMed    


  81. MATTHEWS CR, Hess PJ
    Thirty-three, zero, nine.
    J Thorac Cardiovasc Surg. 2020;160:871-875.
    PubMed    


  82. CHU NQ, Liu R, Colby A, de Forcrand C, et al
    Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.
    J Thorac Cardiovasc Surg. 2020;160:e159-e168.
    PubMed     Abstract available


  83. ZHANG Y, Jheon S, Li H, Zhang H, et al
    Results of low-dose computed tomography as a regular health examination among Chinese hospital employees.
    J Thorac Cardiovasc Surg. 2020;160:824-831.
    PubMed     Abstract available


    August 2020
  84. STILES BM
    Commentary: Overcoming the dangerous narrative of computed tomography screening for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 28. pii: S0022-5223(20)32464.
    PubMed    


  85. BRUNELLI A, Chaudhuri N, Kefaloyannis M, Milton R, et al
    Eurolung risk score is associated with long-term survival after curative resection for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 24. pii: S0022-5223(20)32431.
    PubMed     Abstract available


  86. CHEN KN
    Commentary: Not only safety but also efficacy is required in repeat pulmonary resection for second non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 8. pii: S0022-5223(20)32360.
    PubMed    


  87. LIU C, Tian D, Pu Q
    Do not go too far when choosing intentional segmentectomy for small-sized lung cancers.
    J Thorac Cardiovasc Surg. 2020;160:e85-e86.
    PubMed    


  88. RAZI SS, Nguyen D, Villamizar N
    Reply from authors: Positive nodes after segmentectomy: Take a deep breath and give adjuvant treatment.
    J Thorac Cardiovasc Surg. 2020;160:e86-e87.
    PubMed    


  89. JEFFREY YANG CF, Berry MF
    Reply: The importance of appropriate selection for segmentectomy.
    J Thorac Cardiovasc Surg. 2020;160:e87.
    PubMed    


  90. LAZAR JF
    Commentary: How to "spot" a leopard: It's in the genes.
    J Thorac Cardiovasc Surg. 2020;160:e82-e83.
    PubMed    


  91. PATEL S, Kim AW
    Commentary: Standing on similar, but different, shoulders.
    J Thorac Cardiovasc Surg. 2020;160:e81-e82.
    PubMed    


  92. PENG S, Huang L, Zhao B, Zhou S, et al
    Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis.
    J Thorac Cardiovasc Surg. 2020;160:585-592.
    PubMed     Abstract available


  93. HUANG J, Wang A, Kang G, Li D, et al
    Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery.
    J Thorac Cardiovasc Surg. 2020;160:e91-e93.
    PubMed    


  94. FAN L, Yang H, Yu L, Wang Z, et al
    Multicenter, prospective, observational study of a novel technique for preoperative pulmonary nodule localization.
    J Thorac Cardiovasc Surg. 2020;160:532-539.
    PubMed     Abstract available


    July 2020
  95. D'ANDRILLI A, Rendina EA
    Commentary: Second ipsilateral metachronous lung cancer: What to do?
    J Thorac Cardiovasc Surg. 2020 Jul 24. pii: S0022-5223(20)32224.
    PubMed    


  96. HATTORI A, Matsunaga T, Watanabe Y, Fukui M, et al
    Repeated anatomical pulmonary resection for metachronous ipsilateral second non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 16. pii: S0022-5223(20)32150.
    PubMed     Abstract available


  97. ZAMBETTI BR, Ng T
    Commentary: Patient frailty also drives long-term outcomes after R0 resection for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 14. pii: S0022-5223(20)32079.
    PubMed    


  98. SUDARSHAN M, Murthy SC
    Commentary: Using nutritional scoring systems to predict outcomes after lung cancer surgery: Food for thought.
    J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32051.
    PubMed    


  99. BAZHENOVA L, Urbanic J, Onaitis M
    Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance?
    J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32054.
    PubMed    


  100. WALLACE AF, Weksler B
    Commentary: Food for thought: Assessing the influence of malnutrition in patients with lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 10. pii: S0022-5223(20)32042.
    PubMed    


  101. NELSON DB, Antonoff MB
    Commentary: The prognostic value of Kirsten rat sarcoma viral oncogene mutation for non-small cell lung cancer: One size does not always fit all.
    J Thorac Cardiovasc Surg. 2020 Jul 5. pii: S0022-5223(20)31990.
    PubMed    


  102. STILES BM, Sepesi B, Broderick SR, Bott MJ, et al
    Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 5. pii: S0022-5223(20)31987.
    PubMed    


  103. SALAZAR MC, Boffa DJ
    Commentary: The majority of minorities.
    J Thorac Cardiovasc Surg. 2020;160:272-273.
    PubMed    


  104. HAMMOUD ZT
    Commentary: Despair and disparity.
    J Thorac Cardiovasc Surg. 2020;160:275.
    PubMed    


  105. CORNWELL LD, Ripley RT
    Commentary: Beyond the eyeball test.
    J Thorac Cardiovasc Surg. 2020;160:285-286.
    PubMed    


  106. JONES GD, Tan KS, Caso R, Dycoco J, et al
    Time-varying analysis of readmission and mortality during the first year after pneumonectomy.
    J Thorac Cardiovasc Surg. 2020;160:247-255.
    PubMed     Abstract available


    June 2020
  107. TAKAHASHI M, Sowa T, Tokumasu H, Gomyoda T, et al
    Comparison of three nutritional scoring systems for outcomes after complete resection of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 29. pii: S0022-5223(20)31751.
    PubMed     Abstract available


  108. MUNIAPPAN A
    Commentary: Through the looking glass-radiomics and evaluation of early lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 26. pii: S0022-5223(20)31771.
    PubMed    


  109. LIN J
    Commentary: Mind the gap: Adherence to quality measures for stage I/II non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 26. pii: S0022-5223(20)31753.
    PubMed    


  110. TANG A, Ahmad U, Toth AJ, Bourdakos N, et al
    Non-small cell lung cancer in never- and ever-smokers: Is it the same disease?
    J Thorac Cardiovasc Surg. 2020 Jun 18. pii: S0022-5223(20)31395.
    PubMed     Abstract available


  111. GILES AE, Kidane B
    Commentary: Know your enemy-Understanding futility in the battle against malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;159:2523-2524.
    PubMed    


  112. HOANG CD
    Commentary: Surgeon versus mesothelioma in a thoracic cage match.
    J Thorac Cardiovasc Surg. 2020;159:2522-2523.
    PubMed    


  113. ANDRADE R
    Commentary: Why do uniportal video-assisted thoracoscopic lobectomy?
    J Thorac Cardiovasc Surg. 2020;159:2496-2497.
    PubMed    


  114. BOFFA DJ, Salazar M
    Commentary: How surprising.
    J Thorac Cardiovasc Surg. 2020;159:2483-2484.
    PubMed    


  115. DE PERROT M
    Commentary: Is thoracic cage volume a new parameter for clinical staging in mesothelioma?
    J Thorac Cardiovasc Surg. 2020;159:2520-2521.
    PubMed    


  116. BURT BM, Lee HS, Raghuram AC, Strange C, et al
    Preoperative prediction of unresectability in malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;159:2512-2520.
    PubMed     Abstract available


  117. HYLTON DA, Turner S, Kidane B, Spicer J, et al
    The Canada Lymph Node Score for prediction of malignancy in mediastinal lymph nodes during endobronchial ultrasound.
    J Thorac Cardiovasc Surg. 2020;159:2499-2507.
    PubMed     Abstract available


  118. VIEIRA A, Bourdages-Pageau E, Kennedy K, Ugalde PA, et al
    The learning curve on uniportal video-assisted thoracic surgery: An analysis of proficiency.
    J Thorac Cardiovasc Surg. 2020;159:2487-2495.
    PubMed     Abstract available


    May 2020
  119. DONINGTON JS, Paulus R, Edelman MJ, Krasna MJ, et al
    Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 31. pii: S0022-5223(20)31276.
    PubMed     Abstract available


  120. SESTI J, Paul S
    Commentary: More science, less fortunetelling: Using radiomics to predict the invasiveness of lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 25. pii: S0022-5223(20)31268.
    PubMed    


  121. DIMOU A, Nasarre C, Peterson YK, Pagano R, et al
    Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 25. pii: S0022-5223(20)31233.
    PubMed     Abstract available


  122. RAJARAM R, Rice DC, Li Y, Bruera E, et al
    Postoperative opioid use after lobectomy for primary lung cancer: A propensity-matched analysis of premier hospital data.
    J Thorac Cardiovasc Surg. 2020 May 16. pii: S0022-5223(20)31136.
    PubMed     Abstract available


  123. PASS HI
    Commentary: Not only SMART clinically, but translationally!
    J Thorac Cardiovasc Surg. 2020;159:2094-2095.
    PubMed    


  124. BRUNELLI A
    Commentary: The power of indeterminacy.
    J Thorac Cardiovasc Surg. 2020;159:2041.
    PubMed    


  125. SESTI J, Paul S
    Commentary: Known unknowns and unknown unknowns: The case of the indeterminate margin.
    J Thorac Cardiovasc Surg. 2020;159:2042.
    PubMed    


  126. CHEN-YOSHIKAWA TF
    Commentary: A journey of a thousand miles begins with a single step.
    J Thorac Cardiovasc Surg. 2020;159:2092-2093.
    PubMed    


  127. SRINATHAN S
    Is ventilatory efficiency the next new thing in prehabilitation?
    J Thorac Cardiovasc Surg. 2020;159:e323-e324.
    PubMed    


  128. WAKEAM E, Adibfar A, Stokes S, Leighl NB, et al
    Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
    J Thorac Cardiovasc Surg. 2020;159:2043-2054.
    PubMed     Abstract available


  129. MOLINA JC, Chaudry F, Menezes V, Ferraro P, et al
    Transvascular endosonographic-guided needle biopsy of intrathoracic lesions.
    J Thorac Cardiovasc Surg. 2020;159:2057-2065.
    PubMed     Abstract available


    April 2020
  130. DONINGTON J
    Commentary: Why does neoadjuvant therapy suddenly make sense for early stage non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2020 Apr 25. pii: S0022-5223(20)30999.
    PubMed    


  131. DENLINGER CE
    Commentary: Durable activity of a tyrosine kinase inhibitor in lung cancer.
    J Thorac Cardiovasc Surg. 2020 Apr 23. pii: S0022-5223(20)30985.
    PubMed    


  132. AZZOLI CG, Ng T
    Commentary: Preoperative gefitinib for stage II-III non-small cell lung cancer with EGFR mutation: A stich in time, or delay from stiches?
    J Thorac Cardiovasc Surg. 2020 Apr 18. pii: S0022-5223(20)30967.
    PubMed    


  133. HOANG CD
    Commentary: Smoke or fire? Resected lung cancer in never-smokers.
    J Thorac Cardiovasc Surg. 2020 Apr 10. pii: S0022-5223(20)30795.
    PubMed    


  134. LIM K, Hsin MKY
    Commentary: Resection for small cell lung cancer should be offered more often, and preferably anatomical.
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30780.
    PubMed    


  135. JEFFREY YANG CF
    Commentary: Is surgery better than chemoradiation for T3N1M0 non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30805.
    PubMed    


  136. HATTORI A, Suzuki K, Takamochi K, Wakabayashi M, et al
    Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30734.
    PubMed     Abstract available


  137. LANUTI M
    Commentary: Wedge resection for limited-stage small cell lung cancer: Not an acceptable modality for curative intent.
    J Thorac Cardiovasc Surg. 2020 Apr 5. pii: S0022-5223(20)30811.
    PubMed    


  138. PASS HI
    Commentary: "Hot" gene signatures for checkpoint response prediction: A very cool idea.
    J Thorac Cardiovasc Surg. 2020;159:1611-1612.
    PubMed    


  139. WAKEAM E, Kidane B
    Commentary: Picking the winners-Leaning into selection bias.
    J Thorac Cardiovasc Surg. 2020;159:1594-1595.
    PubMed    


  140. BLESSING WA, Colson YL
    Commentary: The checkpoint before checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2020;159:1614-1615.
    PubMed    


  141. PATEL S, Kim AW
    Commentary: TiME may actually tell good from bad.
    J Thorac Cardiovasc Surg. 2020;159:1613-1614.
    PubMed    


  142. PASS HI
    Discussion.
    J Thorac Cardiovasc Surg. 2020;159:1609-1610.
    PubMed    


  143. WOLF AS
    Discussion.
    J Thorac Cardiovasc Surg. 2020;159:1556.
    PubMed    


  144. SUBRAMANIAN MP
    Commentary: Much to do about nodules-Improving care with a multidisciplinary pulmonary nodule clinic.
    J Thorac Cardiovasc Surg. 2020;159:1569-1570.
    PubMed    


  145. PARK CH, Lee SM, Lee JW, Hwang SH, et al
    Hook-wire localization versus lipiodol localization for patients with pulmonary lesions having ground-glass opacity.
    J Thorac Cardiovasc Surg. 2020;159:1571-1579.
    PubMed     Abstract available


  146. NGUYEN DM, Villamizar N
    Commentary: Preoperative localization of "hard-to-find" pulmonary ground-glass opacity: There are more than one way to find the target.
    J Thorac Cardiovasc Surg. 2020;159:1581-1583.
    PubMed    


  147. MADARIAGA ML, Lennes IT, Best T, Shepard JO, et al
    Multidisciplinary selection of pulmonary nodules for surgical resection: Diagnostic results and long-term outcomes.
    J Thorac Cardiovasc Surg. 2020;159:1558-1566.
    PubMed     Abstract available


  148. FELMLY LM, Gibney BC
    Commentary: Biphasic malignant mesothelioma-Survival of the fittest.
    J Thorac Cardiovasc Surg. 2020;159:1596-1597.
    PubMed    


  149. SESTI J, Paul S
    Commentary: GGOogle maps for the adult lung.
    J Thorac Cardiovasc Surg. 2020;159:1580.
    PubMed    


  150. LOCOCO F, Torricelli F, Lang-Lazdunski L, Veronesi G, et al
    Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    J Thorac Cardiovasc Surg. 2020;159:1584-1593.
    PubMed     Abstract available


    March 2020
  151. OPITZ I
    Commentary: Surgery expanding to stage IV non-small cell lung cancer treatment?!
    J Thorac Cardiovasc Surg. 2020 Mar 31. pii: S0022-5223(20)30731.
    PubMed    


  152. MITCHELL KG, Farooqi A, Ludmir EB, Corsini EM, et al
    Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 25. pii: S0022-5223(20)30633.
    PubMed     Abstract available


  153. XIE D, Deng J, Gonzalez-Rivas D, Zhu Y, et al
    Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 25. pii: S0022-5223(20)30719.
    PubMed     Abstract available


  154. CHAN EG, Chan PG, Mazur SN, Normolle DP, et al
    Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30706.
    PubMed     Abstract available


  155. PATNAIK SK, Cortes EG, Kannisto ED, Punnanitinont A, et al
    Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30631.
    PubMed     Abstract available


  156. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 22. pii: S0022-5223(20)30634.
    PubMed     Abstract available


  157. CHOI JJ, Huang J
    Commentary: How much is enough? The extent of resection in small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30588.
    PubMed    


  158. PASS HI
    Commentary: Lung cancer and dysbiosis: Debugging the studies for the future.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30619.
    PubMed    


  159. ZHANG Y, Fu F, Hu H, Wang S, et al
    Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: A phase II study.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30625.
    PubMed     Abstract available


    February 2020
  160. HONG TH, Kim J, Shin S, Kim HK, et al
    Clinical outcomes of microscopic residual disease after bronchial sleeve resection for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Feb 29. pii: S0022-5223(20)30518.
    PubMed     Abstract available


  161. RAHOUMA M, Kamel M, Nasar A, Harrison S, et al
    Treatment of cT3N1M0/IIIA non-small cell lung cancer and the risk of underuse of surgery.
    J Thorac Cardiovasc Surg. 2020 Feb 24. pii: S0022-5223(20)30503.
    PubMed     Abstract available


  162. JAKLITSCH MT, Jacobson FL
    The future of lung cancer screening with low-dose computed tomography.
    J Thorac Cardiovasc Surg. 2020 Feb 19. pii: S0022-5223(20)30199.
    PubMed    


  163. NGUYEN DM, Villamizar N
    Commentary: Lower airway microbiome and non-small cell lung cancer: The beginning of a bug story.
    J Thorac Cardiovasc Surg. 2020 Feb 14. pii: S0022-5223(20)30382.
    PubMed    


  164. NELSON DB, Niu J, Mitchell KG, Antonoff MB, et al
    Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020;159:691-702.
    PubMed     Abstract available


  165. BOTT MJ
    Commentary: Opioid dependence in the lobectomy patient: A hard pill to swallow.
    J Thorac Cardiovasc Surg. 2020;159:703-704.
    PubMed    


  166. BACIEWICZ FA JR
    Preoperative pulmonary rehabilitation.
    J Thorac Cardiovasc Surg. 2020;159:e147-e148.
    PubMed    


  167. LINDEN PA, Perry Y, Worrell S, Wallace A, et al
    Postoperative day 1 discharge after anatomic lung resection: A Society of Thoracic Surgeons database analysis.
    J Thorac Cardiovasc Surg. 2020;159:667-678.
    PubMed     Abstract available


    January 2020
  168. ZHANG Y, Chen C, Hu J, Han Y, et al
    Early outcomes of robotic versus thoracoscopic segmentectomy for early-stage lung cancer: A multi-institutional propensity score-matched analysis.
    J Thorac Cardiovasc Surg. 2020 Jan 25. pii: S0022-5223(20)30226.
    PubMed     Abstract available


  169. WIESEL O, Burt BM
    Commentary: The A, C, G, and Ts of differentiating stage I and stage IV lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 17. pii: S0022-5223(19)37103.
    PubMed    


  170. LIN J
    Commentary: Through the looking glass: Is the consolidation/tumor ratio more important than size for clinical T1N0 lung cancer with a dominant ground-glass opacity?
    J Thorac Cardiovasc Surg. 2020 Jan 11. pii: S0022-5223(20)30071.
    PubMed    


  171. ITO H, Suzuki K, Mizutani T, Aokage K, et al
    Long-term survival outcome after lobectomy in patients with clinical T1 N0 lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 11. pii: S0022-5223(20)30054.
    PubMed     Abstract available


  172. RANDHAWA SK, Puri V
    Commentary: The changing risk paradigm in lung cancer: Are we opening Pandora's box?
    J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43494.
    PubMed    


  173. CHIDI A, Broderick SR
    Commentary: Chemo if you can-disparities in receipt of guideline-concordant adjuvant therapy in patients with locoregional non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43489.
    PubMed    


    December 2019
  174. WU J, Bai HX, Chan L, Su C, et al
    Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
    J Thorac Cardiovasc Surg. 2019 Dec 26. pii: S0022-5223(19)41497.
    PubMed     Abstract available


  175. YANG CJ, Berry MF
    Commentary: Resection of clinical early-stage lung cancer with unexpected nodal disease-can less really be the same?
    J Thorac Cardiovasc Surg. 2019 Dec 26. pii: S0022-5223(19)41495.
    PubMed    


  176. WHYTE RI
    Commentary: On-demand computed tomography screening for lung cancer-some surprising results.
    J Thorac Cardiovasc Surg. 2019 Dec 24. pii: S0022-5223(19)40870.
    PubMed    


  177. ZHENG R, Shen Q, Mardekian S, Solomides C, et al
    Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Dec 20. pii: S0022-5223(19)39883.
    PubMed     Abstract available


  178. BOYS J, Onaitis M
    Commentary: Breaking down non-small cell lung cancer tumor microenvironment heterogeneity and predicting response to immune checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2019 Dec 16. pii: S0022-5223(19)36852.
    PubMed    


  179. BRUNELLI A
    Commentary: Soft prognosticators following radical treatment of lung cancer: The time has come for a more integrated approach.
    J Thorac Cardiovasc Surg. 2019 Dec 14. pii: S0022-5223(19)37105.
    PubMed    


  180. LEE IH, Chen CY
    Commentary: The role of low-dose computed tomography for lung cancer screening among the nonsmoking Asian population.
    J Thorac Cardiovasc Surg. 2019 Dec 12. pii: S0022-5223(19)37081.
    PubMed    


  181. RHODIN KE, Rucker AJ, Ready NE, D'Amico TA, et al
    The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons.
    J Thorac Cardiovasc Surg. 2019 Dec 10. pii: S0022-5223(19)32182.
    PubMed     Abstract available


  182. NWOGU CE
    Commentary: Are two local therapies better than one for early-stage small cell lung cancer?
    J Thorac Cardiovasc Surg. 2019;158:1679.
    PubMed    


  183. SIHAG S
    Commentary: Surgery for N3 disease: Next frontier or has this ship already sailed?
    J Thorac Cardiovasc Surg. 2019;158:1695-1697.
    PubMed    


  184. YANG SC
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1675-1677.
    PubMed    


  185. HUANG J
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1691-1692.
    PubMed    


    November 2019
  186. VIEIRA A, Ugalde PA
    Commentary: Sleeve lobectomy for centrally located non-small cell lung cancer: Should the approach be a matter of debate?
    J Thorac Cardiovasc Surg. 2019 Nov 30. pii: S0022-5223(19)34024.
    PubMed    


  187. CHEN KN
    Commentary: Pay attention to low-risk populations for lung cancer, but cautiously interpret ground-glass nodules screened by low-dose computed tomography scan.
    J Thorac Cardiovasc Surg. 2019 Nov 27. pii: S0022-5223(19)33476.
    PubMed    


  188. PALEIRON N, Grassin F, Lancelin C, Tromeur C, et al
    Assessment of preoperative noninvasive ventilation before lung cancer surgery: The preOVNI randomized controlled study.
    J Thorac Cardiovasc Surg. 2019 Nov 23. pii: S0022-5223(19)33106.
    PubMed     Abstract available


  189. QIU T, Zhao Y, Xuan Y, Qin Y, et al
    Robotic sleeve lobectomy for centrally located non-small cell lung cancer: A propensity score-weighted comparison with thoracoscopic and open surgery.
    J Thorac Cardiovasc Surg. 2019 Nov 22. pii: S0022-5223(19)33072.
    PubMed     Abstract available


  190. RAZI SS, Nguyen D, Villamizar N
    Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
    J Thorac Cardiovasc Surg. 2019 Nov 21. pii: S0022-5223(19)33080.
    PubMed     Abstract available


  191. FARROW NE, An SJ, Speicher PJ, Harpole DH Jr, et al
    Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
    J Thorac Cardiovasc Surg. 2019 Nov 13. pii: S0022-5223(19)32486.
    PubMed     Abstract available


  192. JANG HJ, Lee HS, Ramos D, Park IK, et al
    Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2019 Nov 11. pii: S0022-5223(19)32515.
    PubMed     Abstract available


  193. PARK S, Ahn HJ, Yang M, Kim JA, et al
    The prognostic nutritional index and postoperative complications after curative lung cancer resection: A retrospective cohort study.
    J Thorac Cardiovasc Surg. 2019 Nov 6. pii: S0022-5223(19)32490.
    PubMed     Abstract available


  194. TITAN AL, He H, Lui N, Liou D, et al
    The influence of hormone replacement therapy on lung cancer incidence and mortality.
    J Thorac Cardiovasc Surg. 2019 Nov 5. pii: S0022-5223(19)32348.
    PubMed     Abstract available


  195. BRODERICK SR, Bott MJ
    Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019;158:1471-1474.
    PubMed    


  196. KNEUERTZ PJ, Cheufou DH, D'Souza DM, Mardanzai K, et al
    Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019;158:1457-1466.
    PubMed     Abstract available


  197. BERRY MF
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1465-1466.
    PubMed    


  198. CERFOLIO RJ
    Commentary: Do we have the right combatants? Should it be minimally invasive surgery versus therapy that removes no lymph nodes?
    J Thorac Cardiovasc Surg. 2019;158:1467-1468.
    PubMed    


  199. GONZALEZ-RIVAS D, Rami-Porta R
    Commentary: Intraoperative lymph node assessment by robotic, video-assisted thoracoscopic surgery, and thoracotomy: None meet the international recommendations.
    J Thorac Cardiovasc Surg. 2019;158:1469-1470.
    PubMed    


    October 2019
  200. KOZOWER BD
    Commentary: The association between hormone-replacement therapy and non-small cell lung cancer in women.
    J Thorac Cardiovasc Surg. 2019 Oct 15. pii: S0022-5223(19)32198.
    PubMed    


  201. KOZOWER BD
    Commentary: Lung cancer resection in the United States: Is regionalization the answer?
    J Thorac Cardiovasc Surg. 2019 Oct 15. pii: S0022-5223(19)32200.
    PubMed    


  202. LIU R, Kidane B
    Commentary: Detection is only part of the equation-Does elevated risk alone warrant screening?
    J Thorac Cardiovasc Surg. 2019;158:1255-1256.
    PubMed    



  203. Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1240-1241.
    PubMed    


    September 2019
  204. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 30. pii: S0022-5223(19)32082.
    PubMed     Abstract available


  205. SEPESI B, Cascone T
    Commentary: Neoadjuvant checkpoint inhibitors in resectable non-small cell lung cancer-Ready for prime time?
    J Thorac Cardiovasc Surg. 2019 Sep 24. pii: S0022-5223(19)32035.
    PubMed    


  206. ABBAS AE
    Commentary: Robotic anatomic lung resection: Raising the bar of our expectations in treating lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 24. pii: S0022-5223(19)32045.
    PubMed    


  207. SEPESI B
    Commentary: Surgery for N3 non-small cell lung cancer-utopia or future reality?
    J Thorac Cardiovasc Surg. 2019 Sep 23. pii: S0022-5223(19)31929.
    PubMed    


  208. TAYLOR M, Okereke I
    Commentary: Is radiation needed after resecting an early-stage small cell lung cancer?
    J Thorac Cardiovasc Surg. 2019 Sep 20. pii: S0022-5223(19)31888.
    PubMed    


  209. ALTORKI N, Stiles B
    Commentary: High-dose induction chemoradiation for lung cancer: The past is prologue.
    J Thorac Cardiovasc Surg. 2019 Sep 20. pii: S0022-5223(19)31873.
    PubMed    


  210. CAO C, Louie BE, Melfi F, Veronesi G, et al
    Outcomes of major complications after robotic anatomic pulmonary resection.
    J Thorac Cardiovasc Surg. 2019 Sep 18. pii: S0022-5223(19)31809.
    PubMed     Abstract available


  211. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31760.
    PubMed     Abstract available


  212. ENGELHARDT KE, Coughlin JM, DeCamp MM, Denlinger CE, et al
    Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection.
    J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31758.
    PubMed     Abstract available


  213. BOTT MJ
    Commentary: Cell proliferation and immune evasion: A dangerous combination.
    J Thorac Cardiovasc Surg. 2019;158:920-921.
    PubMed    


  214. DUX J, Grosser R, Adusumilli PS
    Commentary: Return to intended radiation therapy-Criteria for resection?
    J Thorac Cardiovasc Surg. 2019;158:930-931.
    PubMed    


    August 2019
  215. JIANG L, Huang W, Liu J, Harris K, et al
    Endosonography with lymph node sampling for restaging the mediastinum in lung cancer: A systematic review and pooled data analysis.
    J Thorac Cardiovasc Surg. 2019 Aug 28. pii: S0022-5223(19)31649.
    PubMed     Abstract available


  216. YAMAMICHI T, Shimada Y, Masuno R, Ohira T, et al
    Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
    J Thorac Cardiovasc Surg. 2019 Aug 28. pii: S0022-5223(19)31659.
    PubMed     Abstract available


  217. PANI E, Kennedy G, Zheng X, Ukert B, et al
    Factors associated with nodal metastasis in 2-centimeter or less non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Aug 25. pii: S0022-5223(19)31643.
    PubMed     Abstract available


    July 2019
  218. DONINGTON JS, Martin LW
    Commentary: The need to RIOT (return to intended oncologic treatment) after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2019;158:287-288.
    PubMed    


  219. MOLINA JC, Liberman M
    Commentary: Pulling an entire lung out of a small incision-Video-assisted thoracoscopic surgical pneumonectomy, the final frontier in minimally invasive thoracic surgery.
    J Thorac Cardiovasc Surg. 2019;158:267-268.
    PubMed    


    May 2019
  220. LUI NS
    Commentary: Should lung cancer screening guidelines go up in smoke?
    J Thorac Cardiovasc Surg. 2019 May 31. pii: S0022-5223(19)31140.
    PubMed    


  221. GROTH SS, Ripley RT, Carrott P, Burt BM, et al
    Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma.
    J Thorac Cardiovasc Surg. 2019 May 30. pii: S0022-5223(19)31150.
    PubMed    


  222. KOZOWER BD
    Commentary: Invasive mediastinal staging for patients with lung cancer-We need to do better!
    J Thorac Cardiovasc Surg. 2019 May 24. pii: S0022-5223(19)31112.
    PubMed    


  223. FARJAH F, Silvestri GA, Wood DE
    Commentary: Invasive mediastinal staging for lung cancer-Quality gap, evidence gap, both?
    J Thorac Cardiovasc Surg. 2019 May 24. pii: S0022-5223(19)31113.
    PubMed    


  224. BRAVO-INIGUEZ CE, Fox SW, De Leon LE, Tarascio JN, et al
    Cumulative nonsmoking risk factors increase the probability of developing lung cancer.
    J Thorac Cardiovasc Surg. 2019 May 18. pii: S0022-5223(19)31038.
    PubMed     Abstract available


  225. MITCHELL KG, Parra ER, Nelson DB, Zhang J, et al
    Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 May 17. pii: S0022-5223(19)31015.
    PubMed     Abstract available


  226. LUI NS
    Commentary: Pleomorphic carcinoma: An aggressive type of non-small cell lung cancer that should be treated like the others.
    J Thorac Cardiovasc Surg. 2019 May 16. pii: S0022-5223(19)31004.
    PubMed    


  227. NELSON DB, Tayob N, Nguyen QN, Erasmus J, et al
    Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2019 May 11. pii: S0022-5223(19)30972.
    PubMed     Abstract available


  228. OSAROGIAGBON RU, Lee YS, Faris NR, Ray MA, et al
    Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    J Thorac Cardiovasc Surg. 2019 May 2. pii: S0022-5223(19)30968.
    PubMed     Abstract available


  229. PREDINA JD, Newton AD, Corbett C, Shin M, et al
    Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas.
    J Thorac Cardiovasc Surg. 2019;157:2061-2069.
    PubMed     Abstract available


  230. KAMEL MK, Lee B, Harrison S, Port JL, et al
    Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?
    J Thorac Cardiovasc Surg. 2019;157:2038-2046.
    PubMed     Abstract available


    April 2019
  231. LANUTI M
    Commentary: Cautious optimism for induction immunotherapy in resectable lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30926.
    PubMed    


  232. ALTORKI N, Lee B
    Commentary: Lobectomy or sublobar resection for early lung cancer: One small step for surgeons, one giant step for patients.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30903.
    PubMed    


  233. HENDRIKSEN BS, Hollenbeak CS, Reed MF, Taylor MD, et al
    Perioperative chemotherapy is not associated with improved survival in stage I pleomorphic lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 17. pii: S0022-5223(19)30824.
    PubMed     Abstract available


    March 2019
  234. MOORE CB, Cox ML, Mulvihill MS, Klapper J, et al
    Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Mar 28. pii: S0022-5223(19)30702.
    PubMed     Abstract available


  235. NELSON DB, Mehran RJ, Mitchell KG, Correa AM, et al
    Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Mar 21. pii: S0022-5223(19)30677.
    PubMed     Abstract available


  236. SUBRAMANIAN M, Liu J, Greenberg C, Schumacher J, et al
    Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?
    J Thorac Cardiovasc Surg. 2019;157:1205-1217.
    PubMed     Abstract available


  237. ODELL DD, Feinglass J, Engelhardt K, Papastefan S, et al
    Evaluation of adherence to the Commission on Cancer lung cancer quality measures.
    J Thorac Cardiovasc Surg. 2019;157:1219-1235.
    PubMed     Abstract available



  238. Discussion.
    J Thorac Cardiovasc Surg. 2019;157:1231-1235.
    PubMed    


    February 2019
  239. STILES BM, Mao J, Harrison S, Lee B, et al
    Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2019 Feb 28. pii: S0022-5223(19)30533.
    PubMed     Abstract available


  240. VAN BERKEL V
    Commentary: Still not enough data yet-Sublobar resection versus lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30461.
    PubMed    


  241. GRAVIER FE, Bonnevie T, Boujibar F, Medrinal C, et al
    Effect of prehabilitation on ventilatory efficiency in non-small cell lung cancer patients: A cohort study.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30448.
    PubMed     Abstract available


  242. LATIF MJ, Tan KS, Molena D, Huang J, et al
    Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 12. pii: S0022-5223(19)30351.
    PubMed     Abstract available


    January 2019
  243. SALTER KD, Burt BM
    Commentary: Postoperative blood transplantation for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Jan 25. pii: S0022-5223(19)30259.
    PubMed    


  244. GUCKENBERGER M, Aerts JG, Van Schil P, Weder W, et al
    The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.
    J Thorac Cardiovasc Surg. 2019;157:358-361.
    PubMed    


  245. GROTH SS, Ripley RT, Burt BM
    A thinner peel to peel: Pleural thickness is prognostic in mesothelioma.
    J Thorac Cardiovasc Surg. 2019;157:414-415.
    PubMed    


  246. SEMENKOVICH TR, Puri V
    Surgery versus stereotactic body radiation therapy: Definitive evidence is still elusive.
    J Thorac Cardiovasc Surg. 2019;157:374-375.
    PubMed    


  247. OKADA M, Miyata Y, Takamochi K, Tsutani Y, et al
    Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery.
    J Thorac Cardiovasc Surg. 2019;157:388-395.
    PubMed     Abstract available


    December 2018
  248. SAMSON P
    It's time to check our bias: Ensuring health equity for patients with lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 27. pii: S0022-5223(18)33499.
    PubMed    


  249. HSIN MK, Ho JC
    It is not as bad as they say: The risks of surgery in screening-detected lung cancer are overstated.
    J Thorac Cardiovasc Surg. 2018 Dec 25. pii: S0022-5223(18)33482.
    PubMed    


  250. YANG CJ, Yendamuri S, Mayne NR, Battoo A, et al
    The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study.
    J Thorac Cardiovasc Surg. 2018 Dec 18. pii: S0022-5223(18)33419.
    PubMed     Abstract available


  251. BOTT MJ, Yang SC, Park BJ, Adusumilli PS, et al
    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 13. pii: S0022-5223(18)33277.
    PubMed     Abstract available


  252. WOLF A, Alpert N, Tran BV, Liu B, et al
    Persistence of racial disparities in early-stage lung cancer treatment.
    J Thorac Cardiovasc Surg. 2018 Dec 11. pii: S0022-5223(18)33258.
    PubMed     Abstract available


  253. FERRARI-LIGHT D, Cerfolio RJ
    Are we really operating on advanced stage non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2018 Dec 4. pii: S0022-5223(18)33219.
    PubMed    


  254. OKAMURA A, Watanabe M, Hayami M, Mine S, et al
    Esophagectomy via upper partial sternotomy for esophageal cancer after previous right pneumonectomy: A case report.
    J Thorac Cardiovasc Surg. 2018;156:e217-e220.
    PubMed    


    November 2018
  255. FERNANDEZ FG, Kosinski AS, Tong BC, Furnary AP, et al
    Lack of correlation between short- and long-term performance after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018 Nov 27. pii: S0022-5223(18)33141.
    PubMed     Abstract available


  256. NELSON DB, Tayob N, Mitchell KG, Correa AM, et al
    Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2018 Nov 26. pii: S0022-5223(18)33149.
    PubMed     Abstract available


  257. DAVID EA, Andersen SW, Beckett LA, Melnikow J, et al
    Survival benefits associated with surgery for advanced non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 14. pii: S0022-5223(18)32941.
    PubMed     Abstract available


  258. DONINGTON JS
    Keeping surgery relevant in oligometastatic non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 8. pii: S0022-5223(18)32903.
    PubMed    


  259. HARRISON MS, Frye CC, Puri V
    Health metrics in lung cancer care: Measure, improve, repeat.
    J Thorac Cardiovasc Surg. 2018 Nov 2. pii: S0022-5223(18)32879.
    PubMed    


    October 2018
  260. KORST RJ, Santana-Joseph S
    Quality metrics for lung cancer care: Far from perfect, but close to reality.
    J Thorac Cardiovasc Surg. 2018 Oct 28. pii: S0022-5223(18)32858.
    PubMed    


  261. SUBRAMANIAN MP, Puri V
    Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed.
    J Thorac Cardiovasc Surg. 2018 Oct 26. pii: S0022-5223(18)32833.
    PubMed    


  262. FARJAH F, Kessler L
    Rightsizing lung cancer surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 22. pii: S0022-5223(18)32803.
    PubMed    


  263. ZHANG Y, Chen H
    Neoadjuvant or adjuvant chemotherapy for non-small-cell lung cancer: Does the timing matter?
    J Thorac Cardiovasc Surg. 2018 Oct 12. pii: S0022-5223(18)32632.
    PubMed    


  264. BRUNELLI A
    The timing of chemotherapy in multimodality treatment of locally advanced lung cancer: One size does not fit all.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32609.
    PubMed    


  265. BRANDT WS, Yan W, Zhou J, Tan KS, et al
    Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32606.
    PubMed     Abstract available


  266. WANG Y, Yeung JC, Hanna WC, Allison F, et al
    Metachronous or synchronous primary lung cancer in the era of computed tomography surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 6. pii: S0022-5223(18)32556.
    PubMed     Abstract available


    September 2018
  267. CAO C, Wang D, Chung C, Tian D, et al
    A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Sep 15. pii: S0022-5223(18)32347.
    PubMed     Abstract available


  268. ENGELHARDT KE, Feinglass JM, DeCamp MM, Bilimoria KY, et al
    Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time-trend analysis of the National Cancer Data Base.
    J Thorac Cardiovasc Surg. 2018;156:1233-1246.
    PubMed     Abstract available


    August 2018
  269. FERNANDEZ-RODRIGUEZ L, Torres I, Romera D, Galera R, et al
    Prediction of postoperative lung function after major lung resection for lung cancer using volumetric computed tomography.
    J Thorac Cardiovasc Surg. 2018 Aug 2. pii: S0022-5223(18)32018.
    PubMed     Abstract available


    July 2018
  270. LIN J, Fernandez F
    Indications for invasive mediastinal staging for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Jul 21. pii: S0022-5223(18)31872.
    PubMed    


  271. HOANG CD
    Adjuvant chemotherapy in stage I lung cancer: Is more better?
    J Thorac Cardiovasc Surg. 2018 Jul 19. pii: S0022-5223(18)31821.
    PubMed    


  272. WANG S, Xu J, Wang R, Qian F, et al
    Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    J Thorac Cardiovasc Surg. 2018 Jul 18. pii: S0022-5223(18)31779.
    PubMed     Abstract available


  273. UPHAM TC, Onaitis MW
    Video-assisted thoracoscopic surgery versus robot-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;156:365-368.
    PubMed    


    June 2018
  274. SCHRUMP DS, Hong JA
    Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2632-2633.
    PubMed    


    May 2018
  275. HATTORI A, Suzuki K
    New era defining a novel clinical T staging in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2179-2180.
    PubMed    


    April 2018
  276. SWANSON SJ
    Good vibrations-better care for lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Apr 13. pii: S0022-5223(18)30994.
    PubMed    


  277. BRUNELLI A
    It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30962.
    PubMed    


  278. OKIROR L, Harling L, Toufektzian L, King J, et al
    Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30935.
    PubMed     Abstract available


  279. CAO J, Xu J, He Z, Yuan P, et al
    Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2018 Apr 6. pii: S0022-5223(18)30905.
    PubMed     Abstract available


  280. YENDAMURI S, Dhillon SS, Groman A, Dy G, et al
    Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    J Thorac Cardiovasc Surg. 2018 Apr 4. pii: S0022-5223(18)30895.
    PubMed     Abstract available


  281. MAO Q, Xia W, Dong G, Chen S, et al
    A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    J Thorac Cardiovasc Surg. 2018;155:1784-1792.
    PubMed     Abstract available


    March 2018
  282. KRUSER TJ, Mohindra N, DeCamp MM
    One size does not fit all: Nuances in postoperative N2 non-small cell lung cancer management.
    J Thorac Cardiovasc Surg. 2018 Mar 29. pii: S0022-5223(18)30865.
    PubMed    


  283. ISBELL JM, Jones DR, Li BT
    Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30707.
    PubMed    


  284. AJMANI GS, Wang CH, Kim KW, Howington JA, et al
    Surgical quality of wedge resection affects overall survival in patients with early stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30776.
    PubMed     Abstract available


  285. CAMERON RB
    Adherence to lung cancer surgical quality standards is critical for the survival of both our patients and our specialty.
    J Thorac Cardiovasc Surg. 2018 Mar 7. pii: S0022-5223(18)30612.
    PubMed    


  286. SU K, Gao S, Ying J, Zou S, et al
    Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B.
    J Thorac Cardiovasc Surg. 2018 Mar 6. pii: S0022-5223(18)30059.
    PubMed    


  287. ROCCO G
    Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 2. pii: S0022-5223(18)30604.
    PubMed    


  288. BRUNELLI A
    Short-term outcomes do not capture the real value of lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018;155:1311-1312.
    PubMed    


  289. MEHRAN RJ, Martin LW, Roth JA
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:1307.
    PubMed    


    February 2018
  290. SEPESI B, Ye Y, Mitchell KG, Zhang L, et al
    Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Feb 15. pii: S0022-5223(18)30372.
    PubMed     Abstract available


  291. CHENG X, Zheng D, Li Y, Li H, et al
    Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30362.
    PubMed     Abstract available


  292. MUNOZ-LARGACHA JA, Steiling KA, Kathuria H, Charlot M, et al
    Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30308.
    PubMed     Abstract available


  293. THORNBLADE LW, Wood DE, Mulligan MS, Farivar AS, et al
    Variability in invasive mediastinal staging for lung cancer: A multicenter regional study.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30311.
    PubMed     Abstract available


  294. RUSTHOVEN CG, Jones BL, Kavanagh BD
    Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:810-811.
    PubMed    


    January 2018
  295. AHMAD U, Machuzak M
    Electric shock therapy for lung cancer: Taking palliation to the next level.
    J Thorac Cardiovasc Surg. 2018 Jan 31. pii: S0022-5223(18)30245.
    PubMed    


  296. MOGHANAKI D, Simone CB 2nd, Rimner A, Karas TZ, et al
    The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:429-431.
    PubMed    


    December 2017
  297. NOMORI H, Shiraishi A, Cong Y, Shoji K, et al
    Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 26. pii: S0022-5223(17)33059.
    PubMed     Abstract available


  298. RUSCH VW, Chaft J, Hellmann M
    KEYNOTE-024: Unlocking a pathway to lung cancer cure?
    J Thorac Cardiovasc Surg. 2017 Dec 23. pii: S0022-5223(17)33029.
    PubMed    


  299. ROGERS LJ, Bleetman D, Messenger DE, Joshi NA, et al
    The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32855.
    PubMed     Abstract available


  300. DRAKE JA, Sullivan JL, Weksler B
    Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32857.
    PubMed     Abstract available


  301. DIGESU CS, Hachey KJ, Gilmore DM, Khullar OV, et al
    Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 13. pii: S0022-5223(17)32505.
    PubMed     Abstract available


  302. BRUNELLI A
    Time of modeling survival of patients with stage III-N2 non-small cell lung cancer: Before or after surgery makes a difference.
    J Thorac Cardiovasc Surg. 2017 Dec 12. pii: S0022-5223(17)32837.
    PubMed    


    November 2017
  303. GELLER AD, Zheng H, Mathisen DJ, Wright CD, et al
    Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 20. pii: S0022-5223(17)32702.
    PubMed     Abstract available


  304. NEGRAO MV, Quek K, Zhang J, Sepesi B, et al
    TRACERx: Tracking tumor evolution to impact the course of lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 16. pii: S0022-5223(17)32689.
    PubMed    


  305. FERNANDEZ FG, Kosinski AS, Furnary AP, Onaitis M, et al
    Differential effects of operative complications on survival after surgery for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 13. pii: S0022-5223(17)32503.
    PubMed     Abstract available


  306. WEKSLER B
    Resection of pleural implants in patients with lung cancer should remain the exception rather than the rule.
    J Thorac Cardiovasc Surg. 2017 Nov 8. pii: S0022-5223(17)32459.
    PubMed    


  307. LIN J
    Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32471.
    PubMed    


  308. CHENG X, Chen H
    Commentary on the impacts of postoperative complications on survival after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32470.
    PubMed    


  309. ZHENG D, Ye T, Hu H, Zhang Y, et al
    Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 3. pii: S0022-5223(17)32409.
    PubMed     Abstract available


  310. LIU M, Wigle D, Wampfler JA, Dai J, et al
    T category of non-small cell lung cancer invading the fissure to the adjacent lobe.
    J Thorac Cardiovasc Surg. 2017;154:1777-1783.
    PubMed     Abstract available


  311. LANUTI M
    Risk stratification for distant recurrence of resected early stage non-small cell lung cancer is under construction.
    J Thorac Cardiovasc Surg. 2017 Nov 1. pii: S0022-5223(17)32392.
    PubMed    


    October 2017
  312. MOLENA D
    Shining light on sentinel node assessment for lung cancer: Quality is superior to quantity.
    J Thorac Cardiovasc Surg. 2017 Oct 20. pii: S0022-5223(17)32331.
    PubMed    


    September 2017
  313. DETTERBECK FC
    The eighth edition TNM stage classification for lung cancer: What does it mean on main street?
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32136.
    PubMed    


  314. ZHANG Z, Mostofian F, Ivanovic J, Gilbert S, et al
    All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32135.
    PubMed     Abstract available


  315. TURNA A, Melek H, Kara HV, Kilic B, et al
    Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Sep 27. pii: S0022-5223(17)32131.
    PubMed     Abstract available


  316. CERFOLIO RJ, Ghanim AF, Dylewski M, Veronesi G, et al
    The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.
    J Thorac Cardiovasc Surg. 2017 Sep 18. pii: S0022-5223(17)31919.
    PubMed     Abstract available


  317. GILBERT CR, Ely R, Fathi JT, Louie BE, et al
    The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic.
    J Thorac Cardiovasc Surg. 2017 Sep 13. pii: S0022-5223(17)31890.
    PubMed     Abstract available


  318. SEDER CW
    Lung cancer screening is here to stay, but does it pay?
    J Thorac Cardiovasc Surg. 2017 Sep 12. pii: S0022-5223(17)31887.
    PubMed    


  319. ANTONOFF MB
    Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?
    J Thorac Cardiovasc Surg. 2017 Sep 8. pii: S0022-5223(17)31866.
    PubMed    


  320. TONG BC
    Lung cancer screening: No more excuses.
    J Thorac Cardiovasc Surg. 2017 Sep 5. pii: S0022-5223(17)31853.
    PubMed    


  321. LIU C, Liu L
    Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134.
    PubMed    


  322. DIGESU CS, Colson YL
    A "green" light for staging in early lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134-1136.
    PubMed    


  323. FLORES RM
    Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31820.
    PubMed    


  324. KIDANE B
    Stereotactic body radiation therapy versus video-assisted thoracoscopic surgery in stage I lung cancer: Honesty in the face of uncertainty.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31821.
    PubMed    


  325. HATTORI A, Matsunaga T, Takamochi K, Oh S, et al
    Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31798.
    PubMed     Abstract available


  326. BURT BM
    Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31823.
    PubMed    


    August 2017
  327. CORNWELL LD, Echeverria AE, Samuelian J, Mayor J, et al
    Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    J Thorac Cardiovasc Surg. 2017 Aug 16. pii: S0022-5223(17)31718.
    PubMed     Abstract available


    July 2017
  328. FERNANDEZ FG
    What are the gaps in quality measurement for lung cancer surgery?
    J Thorac Cardiovasc Surg. 2017 Jul 1. pii: S0022-5223(17)31367.
    PubMed    


    June 2017
  329. SCHAHEEN LW, D'Cunha J
    The slippery slope of nonoperative therapy in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Jun 10. pii: S0022-5223(17)31178.
    PubMed    


  330. BRANDT WS, Isbell JM, Jones DR
    Defining quality in the surgical care of lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31171.
    PubMed    


    May 2017
  331. CHEN K, Zhang J, Guan T, Yang F, et al
    Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 24. pii: S0022-5223(17)31084.
    PubMed     Abstract available


  332. ZHAO Y, Li G, Zhang Y, Hu H, et al
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 20. pii: S0022-5223(17)31049.
    PubMed     Abstract available


  333. NGUYEN DM, Villamizar N
    "One-stop shop" tumor tattooing and sentinel lymph node mapping: A new paradigm for lung cancer therapy.
    J Thorac Cardiovasc Surg. 2017 May 17. pii: S0022-5223(17)30908.
    PubMed    


    April 2017
  334. WEKSLER B
    One in every 14 patients with early-stage lung cancer is not being treated!
    J Thorac Cardiovasc Surg. 2017 Apr 24. pii: S0022-5223(17)30850.
    PubMed    


  335. HOANG CD
    Protein-based prognostic biomarkers in lung cancer: Promise or pitfall?
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30851.
    PubMed    


  336. FERRARIS VA
    Interstitial lung disease and lung cancer: Decisions, precision, and tuna fish sandwiches.
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30848.
    PubMed    


  337. BURT BM
    Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin?
    J Thorac Cardiovasc Surg. 2017 Apr 12. pii: S0022-5223(17)30689.
    PubMed    


  338. BERRY MF
    Evidence for resection of sarcoma pulmonary metastases: More, but better?
    J Thorac Cardiovasc Surg. 2017 Apr 7. pii: S0022-5223(17)30658.
    PubMed    


  339. MCMURRY TL, Shah PM, Samson P, Robinson CG, et al
    Treatment of stage I non-small cell lung cancer: What's trending?
    J Thorac Cardiovasc Surg. 2017 Apr 5. pii: S0022-5223(17)30643.
    PubMed     Abstract available


  340. YEROKUN BA, Yang CJ, Gulack BC, Li X, et al
    A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30639.
    PubMed     Abstract available


  341. TSUTANI Y, Mimura T, Kai Y, Ito M, et al
    Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30635.
    PubMed     Abstract available


  342. SMELTZER MP, Lin CC, Kong FS, Jemal A, et al
    Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30604.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: